34.21
-1.76
(-4.89%)
At close: January 31 at 4:00:02 PM EST
34.22
+0.01
+(0.03%)
After hours: 7:45:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 5,159,602 | 11 |
| Sales | 6,531,089 | 7 |
| Net Shares Purchased (Sold) | -1,371,487 | 18 |
| Total Insider Shares Held | 5.5M | -- |
| % Net Shares Purchased (Sold) | -20.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KUMAR NEIL Chief Executive Officer | Sale at price 36.29 - 36.82 per share. | Indirect | 21,788,650 | Jan 29, 2025 |
| STEPHENSON BRIAN C Chief Financial Officer | Conversion of Exercise of derivative security at price 17.00 per share. | Direct | 1,156,000 | Jan 28, 2025 |
| STEPHENSON BRIAN C Chief Financial Officer | Sale at price 36.29 per share. | Direct | 2,467,761 | Jan 28, 2025 |
| SATVAT ALI J Director | Conversion of Exercise of derivative security at price 10.99 - 26.21 per share. | Direct | 2,585,134 | Dec 30, 2024 |
| MCCORMICK FRANK Director | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 26, 2024 |
| MCCORMICK FRANK Director | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 26, 2024 |
| KUMAR NEIL Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 24, 2024 |
| TRIMARCHI THOMAS President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 10, 2024 |
| KUMAR NEIL Chief Executive Officer | Sale at price 22.39 - 22.76 per share. | Direct | 613,826 | Nov 19, 2024 |
| STEPHENSON BRIAN C Chief Financial Officer | Sale at price 22.41 per share. | Direct | 93,137 | Nov 19, 2024 |
| STEPHENSON BRIAN C Chief Financial Officer | -- | Direct | -- | Nov 15, 2024 |
| KUMAR NEIL Chief Executive Officer | -- | Direct | -- | Nov 15, 2024 |
| KKR GENETIC DISORDER L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 25.75 per share. | Indirect | 149,350,000 | Sep 13, 2024 |
| KUMAR NEIL Chief Executive Officer | Sale at price 24.39 - 25.13 per share. | Direct | 676,256 | Aug 19, 2024 |
| STEPHENSON BRIAN C Chief Financial Officer | Sale at price 24.39 - 25.13 per share. | Direct | 102,590 | Aug 19, 2024 |
| STEPHENSON BRIAN C Chief Financial Officer | -- | Direct | -- | Aug 16, 2024 |
| KUMAR NEIL Chief Executive Officer | -- | Direct | -- | Aug 16, 2024 |
| TRIMARCHI THOMAS President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 6, 2024 |
| SCOTT RANDAL W Director | Sale at price 28.68 - 31.30 per share. | Indirect | 75,793 | Jun 4, 2024 |
| STEPHENSON BRIAN C Chief Financial Officer | -- | Direct | -- | May 16, 2024 |
| KUMAR NEIL Chief Executive Officer | -- | Direct | -- | May 16, 2024 |
| SCOTT RANDAL W Director | Sale at price 34.00 per share. | Indirect | 85,000 | Mar 1, 2024 |
| STEPHENSON BRIAN C Chief Financial Officer | -- | Direct | -- | Feb 16, 2024 |
| HOMCY CHARLES J Director | -- | Direct | -- | Feb 16, 2024 |
| KUMAR NEIL Chief Executive Officer | -- | Direct | -- | Feb 16, 2024 |
| VALANTINE HANNAH A. M.D. Director | Conversion of Exercise of derivative security at price 8.45 per share. | Direct | 24,632 | Feb 15, 2024 |
| VALANTINE HANNAH A. M.D. Director | Sale at price 37.75 per share. | Direct | 110,041 | Feb 15, 2024 |
| VALANTINE HANNAH A. M.D. Director | Conversion of Exercise of derivative security at price 8.45 per share. | Direct | 24,632 | Jan 16, 2024 |
| VALANTINE HANNAH A. M.D. Director | Sale at price 37.97 per share. | Direct | 110,683 | Jan 16, 2024 |
| MCCORMICK FRANK Director | Sale at price 42.06 per share. | Indirect | 4,206,000 | Dec 26, 2023 |
| SCOTT RANDAL W Director | Sale at price 40.00 per share. | Indirect | 80,000 | Dec 18, 2023 |
| VALANTINE HANNAH A. M.D. Director | Conversion of Exercise of derivative security at price 8.45 per share. | Direct | 24,632 | Dec 15, 2023 |
| VALANTINE HANNAH A. M.D. Director | Sale at price 36.12 per share. | Direct | 105,290 | Dec 15, 2023 |
| SCOTT RANDAL W Director | Sale at price 28.50 - 30.00 per share. | Indirect | 73,500 | Dec 1, 2023 |
| KUMAR NEIL Chief Executive Officer | Sale at price 29.10 - 29.55 per share. | Direct | 1,500,038 | Nov 17, 2023 |
| STEPHENSON BRIAN C Chief Financial Officer | Sale at price 29.10 per share. | Direct | 660,059 | Nov 17, 2023 |
| STEPHENSON BRIAN C Chief Financial Officer | -- | Direct | -- | Nov 16, 2023 |
| HOMCY CHARLES J Director | -- | Direct | -- | Nov 16, 2023 |
| KUMAR NEIL Chief Executive Officer | -- | Direct | -- | Nov 16, 2023 |
| VALANTINE HANNAH A. M.D. Director | Conversion of Exercise of derivative security at price 8.45 per share. | Direct | 24,632 | Nov 15, 2023 |
| VALANTINE HANNAH A. M.D. Director | Sale at price 30.00 per share. | Direct | 87,450 | Nov 15, 2023 |
| SCOTT RANDAL W Director | Sale at price 30.00 per share. | Indirect | 75,000 | Sep 5, 2023 |
| KUMAR NEIL Chief Executive Officer | Sale at price 28.59 per share. | Direct | 1,473,784 | Aug 17, 2023 |
| STEPHENSON BRIAN C Chief Financial Officer | Sale at price 28.59 per share. | Direct | 648,455 | Aug 17, 2023 |
| STEPHENSON BRIAN C Chief Financial Officer | -- | Direct | -- | Aug 16, 2023 |
| HOMCY CHARLES J Director | -- | Direct | -- | Aug 16, 2023 |
| KUMAR NEIL Chief Executive Officer | -- | Direct | -- | Aug 16, 2023 |
| VIKING GLOBAL PERFORMANCE, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 35.00 per share. | Indirect | 52,500,000 | Jul 18, 2023 |
| KUMAR NEIL Chief Executive Officer | Sale at price 14.01 per share. | Direct | 722,218 | May 17, 2023 |
| STEPHENSON BRIAN C Chief Financial Officer | Sale at price 14.01 per share. | Direct | 342,168 | May 17, 2023 |
Related Tickers
CYTK Cytokinetics, Incorporated
49.46
-1.02%
ETNB 89bio, Inc.
9.60
-0.41%
RVMD Revolution Medicines, Inc.
42.95
-0.28%
MDGL Madrigal Pharmaceuticals, Inc.
334.80
-1.03%
SRRK Scholar Rock Holding Corporation
40.38
-0.05%
BPMC Blueprint Medicines Corporation
112.53
-1.33%
ALNY Alnylam Pharmaceuticals, Inc.
271.31
-2.11%
JANX Janux Therapeutics, Inc.
43.48
-2.92%
VRNA Verona Pharma plc
57.30
+0.10%
CRGX CARGO Therapeutics, Inc.
3.6000
+6.19%